stock · yahoo

Intuitive Surgical, Inc.

ISRG

$426.70
▼ 1.16 (-0.27%)
polled · warming up

Below: live stock price for Intuitive Surgical, Inc. (ISRG), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.

Intuitive Surgical, Inc. (ISRG) is a Healthcare company based in United States. Operating in Medical Instruments & Supplies, it employs about 17,021 people. Over the past year ISRG traded between 328.57 and 603.88 USD. Trailing P/E sits near 48.93 on a market cap of about 150.74B USD.

Day
-0.27%
-1.16
Week
+0.65%
+2.74
Month
+8.48%
+33.37
Year
—
Prev close
$427.86
Volume (24h)
$1.11B
Market cap
$150.74B
Currency
USD

Score

58/ 100 · Mixed

Coverage: 7/7
  • Value14
  • Quality78
  • Momentum29
  • Growth56
  • Risk81
  • Dividend50
  • Liquidity100

Composite of public market data. Informational only — not investment advice.

Trend projection

Where the recent trend points if it continues.

UptrendFit 52%Pace +0.24% per bar
+5 bars+20 bars+60 bars+120 bars
+5 bars
430.7503
+0.95%
Bull516.0855
Bear359.5254
+20 bars
436.4021
+2.27%
Bull626.4391
Bear304.0148
+60 bars
438.6083
+2.79%
Bull820.3423
Bear234.5085
+120 bars
438.6894
+2.81%
Bull1,063.43
Bear180.9701

Linear-regression continuation — not a prediction, not investment advice. ±1σ ≈ 68% range · ±2σ ≈ 95% range: ±0.0404 USD.

Interpretation

Composite signals look mixed. Strength: balance-sheet liquidity with weakness: valuation. Price sits near the upper third of the recent range, trend is sloping upward.

Descriptive observation — not investment advice.

Score breakdown

Raw values behind each pillar so you can see what the composite is reading.

  • Value
    14/100

    Value looks fragile — driven by P/E (48.93).

    P/E:48.93P/B:8.31PEG:1.98
  • Quality
    78/100

    Quality looks strong — driven by Gross margin (66.68%).

    ROE:17.42%ROA:10.51%Profit margin:28.45%Gross margin:66.68%
  • Momentum
    29/100

    Momentum looks fragile — driven by 52w change (-6.93%).

    52w change:-6.93%
  • Growth
    56/100

    Growth looks mixed — driven by Earnings growth (26.50%).

    Revenue growth:18.50%Earnings growth:26.50%
  • Risk
    81/100

    Risk looks strong — driven by Beta (1.46).

    Beta:1.46Short interest:2.11%
  • Dividend
    50/100

    Dividend looks mixed — driven by Dividend yield (0.00%).

    Dividend yield:0.00%Payout ratio:0.00%
  • Liquidity
    100/100

    Liquidity looks strong — driven by Current ratio (4.96).

    Current ratio:4.96Quick ratio:3.64

Derived from public market data — informational, not investment advice.

Price report

How this asset has actually moved over the last 250 days.

Position in range36%
328.57 low603.88 high

Where the price sits between the window low and high.

Volatility (annualised)
37.0%

Spread of returns. Higher means larger swings in both directions.

Max drawdown
-44.0%

Worst peak-to-trough fall inside the window.

Below period high
-29.3%

Current price against the highest point in the window.

Best day
+13.89%
Worst day
-14.15%
Up days
49%

Share of days that closed above the one before.

Current streak
1 down
Typical day swing
2.7%

Average high-to-low spread within a single day.

Volume vs average
-22%

Last 10 days against the whole window.

Descriptive statistics over past prices — not a forecast and not investment advice.

Reference levels

Fibonacci retracements and extensions across the recent range.

60 bars

Reference only — not investment advice.

These coordinates describe past-trade clustering, not where to buy or sell. Do your own research before any trade.

Next level above
462.8353 USD+8.47%
Fib +27.2% extension
Next level below
410.6434 USD-3.76%
Fib 23.6% retracement

Levels derived from: 434.89 high → 332.15 low · 60 bars

  • Resistance
    Fib +161.8% extension
    not reached
    601.1234 USD
    +40.88% from current
  • Resistance
    Fib +100% extension
    not reached
    537.63 USD
    +26.00% from current
  • Resistance
    Fib +61.8% extension
    not reached
    498.3833 USD
    +16.80% from current
  • Resistance
    Fib +27.2% extension
    not reached
    462.8353 USD
    +8.47% from current
  • Current
    426.7 USD
  • Support
    Fib 23.6% retracementNearest
    tested 5×
    410.6434 USD
    -3.76% from current
  • Support
    Fib 38.2% retracement
    tested 11×
    395.6433 USD
    -7.28% from current
  • Support
    Fib 50% midpoint
    tested 6×
    383.52 USD
    -10.12% from current
  • Support
    Fib 61.8% retracement
    tested 15×
    371.3967 USD
    -12.96% from current
  • Support
    Fib 78.6% retracement
    tested 7×
    354.1364 USD
    -17.01% from current
  • Support
    Fib −27.2% extension
    not reached
    304.2047 USD
    -28.71% from current
  • Support
    Fib −61.8% extension
    not reached
    268.6567 USD
    -37.04% from current
  • Support
    Fib −100% extension
    not reached
    229.41 USD
    -46.24% from current
How to read this

We take the highest and lowest price of the last 60 bars and cut the gap between them at the classic Fibonacci ratios (23.6%, 38.2%, 50%, 61.8%, 78.6%), plus extensions beyond both ends.

“Tested N×” counts how many of those 60 bars actually traded through the level. A level price has crossed many times is one the market has repeatedly agreed on; a level at 0 is pure geometry the price has never reached.

This is a map of where trading has already happened — not a forecast and not a signal. Price moves through these levels all the time.

Financials

52w high
$603.88
52w low
$328.57
52w change
-6.93%
Day high
$434.89
Day low
$425.51
P/E (TTM)
48.93
Forward P/E
35.24
PEG
1.98
Price / Book
8.31
Beta (5Y)
1.46
Enterprise value
145.66B
EV / Revenue
13.2
EV / EBITDA
34.84
EPS (TTM)
$8.72
Forward EPS
$12.11
Dividend yield
0.00%
Payout ratio
0.00%
Revenue (TTM)
11.03B
EBITDA
4.18B
Free cash flow
2.62B
Total cash
5.22B
Total debt
0
Current ratio
4.96
Quick ratio
3.64
Profit margin
28.45%
Gross margin
66.68%
Return on assets
10.51%
Return on equity
17.42%
Shares outstanding
353.28M
Float
351.21M
Sector: HealthcareIndustry: Medical Instruments & SuppliesHQ: United StatesEmployees: 17.02Kwww.intuitive.com

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.

Analyst & Risk

Consensus
Buy
Mean rating1.76 / 5
Analysts30
Next earnings2026-10-20
Strong buy 8Buy 18Hold 7Sell 1
Analyst price target
$478.53
Mean target · 30 analysts
+12.1%
upside
Low $324.00Now $426.70High $685.00
Beta (vs S&P 500)
1.46
slightly more volatile
52-week change
-6.93%
Short % of float
2.11%
Short ratio (days)
3.1
Current ratio
4.96
Quick ratio
3.64
ROE
17.42%
ROA
10.51%
PEG ratio
1.98
fair
EV / Revenue
13.2
EV / EBITDA
34.84
Revenue growth
18.50%
Earnings growth
26.50%
EBITDA
4.18B
Free cash flow
2.62B
Total cash
5.22B
Total debt
0
Insider holdings
0.51%
Institutional
89.56%

Recent rating changes

  • 2026-10-12BTIGBuy → Buymain
  • 2026-10-07BarclaysOverweightinit
  • 2026-09-08BTIGBuy → Buyreit
  • 2026-08-12OppenheimerPerform → Outperformup
  • 2026-07-30HSBCBuy → Holddown
  • 2026-07-17Raymond JamesOutperform → Outperformmain
  • 2026-07-17Piper SandlerOverweight → Overweightreit
  • 2026-07-17JP MorganOverweight → Overweightmain

Recent news

Related

Other assets in this category.

Learn the terms

Live discussion

Sign in to join the discussion.

  • No comments yet. Be the first.